Document Detail


Effects of Palmitoyl Carnitine on Perfused Heart and Papillary Muscle.
MedLine Citation:
PMID:  10684527     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: Palmitoyl carnitine accumulation during ischemia causes profound electrophysiological changes, resulting in arrhythmias. We studied the electrophysiological and contractile effects of palmitoyl carnitine. METHODS AND RESULTS: Extracellular recordings made by using the endocardial unipolar paced evoked response (PER) in isolated perfused rabbit hearts were compared with action potentials (AP) recorded from septal artery perfused rabbit papillary muscle. Left ventricular pressure was monitored in isolated hearts. In perfused hearts palmitoyl carnitine (30 µmol/L, 30 minutes) significantly (P <.001) increased the latency of activation (St-R interval) by 58% +/- 8% and reduced repolarization time (R-E interval) by 39% +/- 4%. PER duration (St-E interval), was reduced by 30% +/- 3%. Palmitoyl carnitine (30 µmol/L) significantly (P <.001) decreased resting membrane potential (19 +/- 2 mV) of AP, reduced peak amplitude (33.5 +/- 8 mV) and rate of rise of phase 0 (41 +/- 8 V/s). Significant reductions (P <.001) in the action potential duration 50% (129.4 +/- 28 ms) and 90% (139.8 +/- 32 ms) were also observed. An initial positive inotropic effect, which declined as irreversible contracture developed, was also observed. Verapamil (1 µmol/L), nifedipine (1 µmol/L), and caffeine (10 mmol/L) failed to abolish the positive inotropy. CONCLUSIONS: We suggest that palmitoyl carnitine disrupts intracellular calcium homeostasis leading to disturbances in electrical and contractile activity. Its accumulation during myocardial ischemia could contribute to calcium overloading and initiate lethal arrhythmias.
Authors:
Patel; Economides; Byrne
Related Documents :
2729137 - Cardiovascular manifestations of human immunodeficiency virus infection in infants and ...
23634927 - Space-occupying cerebellar infarction: complications, treatment, and outcome.
24250917 - Retrosternal mass: an interesting allergic reaction to intravenous thrombolytic therapy...
20541717 - Contractile reserve in segments with nontransmural infarction in chronic dysfunctional ...
3840397 - Ah23848, a thromboxane antagonist, suppresses ischaemia and reperfusion-induced arrhyth...
21304037 - Thienopyridines in acute coronary syndrome (february).
Publication Detail:
Type:  JOURNAL ARTICLE; JOURNAL ARTICLE    
Journal Detail:
Title:  Journal of cardiovascular pharmacology and therapeutics     Volume:  4     ISSN:  1940-4034     ISO Abbreviation:  J. Cardiovasc. Pharmacol. Ther.     Publication Date:  1999 Apr 
Date Detail:
Created Date:  2000-02-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9602617     Medline TA:  J Cardiovasc Pharmacol Ther     Country:  -    
Other Details:
Languages:  ENG     Pagination:  85-96     Citation Subset:  -    
Affiliation:
Cardiac Electrophysiology Group, Coventry University, Coventry, United Kingdom
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prevention of Vascular Apoptosis in Myocardial Infarction by Losartan.
Next Document:  The Effect of Chloroquine on Circulating Platelet Survival in the Rat.